Amplification of the 3q chromosomal region as a specific marker in cervical cancer

American Journal of Obstetrics and Gynecology

Volumn 213, Issue 1, 2015, Pages 51.e1-51.e8

  Wright, Thomas C ^a,f   Compagno, John ^b   Romano, Patricia ^c   Grazioli, Vittorio ^d   Verma, Yogita ^e   Kershnar, Eric ^e   Tafas, Triantafyllos ^e   Kilpatrick, Michael W ^e  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b West Coast Pathology Laboratories   (United States)

^c Shiel Medical Diagnostic Laboratory   (United States)

^d Centro Diagnostico Italiano   (Italy)

^e Ikonisys Inc   (United States)

^f Research Pathology Associates   (United States)

Author keywords

3q gain; atypical squamous cells of undetermined significance; cervical intraepithelial neoplasia grades 2 and 3; high grade squamous intraepithelial lesion; high risk human papillomavirus; low grade squamous intraepithelial lesion; squamous cell carcinomas

Indexed keywords

BIOLOGICAL MARKER; PROTEIN P16; DNA PROBE;

ARTICLE; CANCER GRADING; CENTROMERE; CHROMOSOME 3Q; CHROMOSOME 7; COLPOSCOPY; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DOSAGE; GENE LOCUS; GENETIC GAIN; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN TISSUE; LIQUID BASED CYTOLOGY; MAJOR CLINICAL STUDY; PATIENT SELECTION; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; ALGORITHM; CHROMOSOME 3; DNA PROBE; GENETICS; PRECANCER; SQUAMOUS INTRAEPITHELIAL LESION OF THE CERVIX; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR;

ALGORITHMS; ATYPICAL SQUAMOUS CELLS OF THE CERVIX; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHROMOSOMES, HUMAN, PAIR 3; DNA PROBES; FEMALE; GENE DOSAGE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; PRECANCEROUS CONDITIONS; SENSITIVITY AND SPECIFICITY; SQUAMOUS INTRAEPITHELIAL LESIONS OF THE CERVIX; UTERINE CERVICAL NEOPLASMS;

EID: 84937518922     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2015.02.001     Document Type: Article

References (21)

1. K. Nanda, D.C. McCrory, E.R. Myers, and et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review Ann Intern Med 132 2000 810 819
2. M. Schiffman, N. Wentzensen, S. Wacholder, and et al. Human papillomavirus testing in the prevention of cervical cancer J Natl Cancer Inst 103 2011 368 383
3. A.B. Moscicki, S. Shiboski, N.K. Hills, and et al. Regression of low-grade squamous intra-epithelial lesions in young women Lancet 364 2004 1678 1683
4. L.A. Koutsky The ALTS Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial J Natl Cancer Inst 92 2000 397 402
5. P.E. Castle, M. Schiffman, C.M. Wheeler, and D. Solomon Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2 Obstet Gynecol 113 2009 18 25
6. N.P. Caraway, A. Khanna, M. Dawlett, and et al. Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma Gynecol Oncol 2008 ScienceDirect Online
7. K. Heselmeyer, M. Macville, E. Schrock, and et al. Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q Genes Chromosom Cancer 19 1997 233 240
8. A.H.N. Hopman, W. Theelen, P.P.H. Hommelberg, and et al. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer J Pathol 210 2006 412 419
9. I. Sokolova, A. Algeciras-Schimnich, M. Song, and et al. Chromosomal biomarkers for detection of human papillomavirus associated genomic instability in epithelial cells of cervical cytology specimens J Mol Diag 9 2007 604 611
10. K. Heselmeyer-Haddad, K. Sommerfeld, N. White, and et al. Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer Am J Pathol 166 2005 1229 1238
11. S. Andersson, P. Sowjanya, D. Wangsa, and et al. Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears Am J Pathol 175 2009 1831 1847
12. A. Seppo, G.R. Jalali, R. Babkowski, and et al. Gain of 3q26: a genetic marker in low-grade squamous intraepithelial lesions (LSIL) of the uterine cervix Gynecol Oncol 114 2009 80 83
13. M.M. Manos, D.K. Wright, A.J. Lewis, and et al. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses M. Furth, M. Greaves, Molecular diagnostics of human cancer 1989 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY 209 214
14. K. Heselmeyer-Haddad, V. Janz, P.E. Castle, and et al. Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia Am J Pathol 163 2003 1405 1416
15. P. Luhn, J. Houldsworth, L. Cahill, and et al. Chromosomal gains measured in cytology samples from women with abnormal cervical cancer screening results Gynecol Oncol 130 2013 595 600
16. M.B. Parshall Unpacking the 2×2 table Heart Lung 42 2013 221 226
17. M.W. Kilpatrick, T. Tafas, M.I. Evans, and et al. Automated detection of rara fetal cells in maternal blood: eliminating the false-positive XY signals in XX pregnancies Am J Obstet Gynecol 190 2004 1571 1581
18. G.R. Jalali, T.J. Herzog, B. Dziura, R. Walat, and M.W. Kilpatrick Amplification of the chromosome 3q26 region shows high negative predictive value for nonmalignant transformation of LSIL cytologic finding Am J Obstet Gynecol 202 2010 581.e1 581.e5
19. P.E. Castle, M.H. Stoler, T.C. Wright, A. Sharma, T.L. Wright, and C.M. Behrens Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study Lancet Oncol 12 2011 880 890
20. E.R. Heitmann, K.M. Lankachandra, J. Wall, and et al. 3q26 amplification is an effective negative triage test for LSIL: a historical prospective study PLoS One 7 2012 e39101
21. A. Rodolakis, I. Biliatis, H. Symiakaki, and et al. Role of chromosome 3q26 in predicting progression of cervical dysplasia Int J Gynecol Cancer 22 2012 742 747